Proto Labs, Inc.PRLBNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank14
5Y CAGR-11.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
-11.2%/yr
Long-term compound
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
202512.17%+0.5%
202412.11%-8.3%
202313.21%+210.4%
2022-11.97%-172.4%
202116.53%-24.9%
202021.99%-10.0%
201924.43%-8.1%
201826.57%-1.5%
201726.97%-1.6%
201627.41%-